Atrimed Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 8.50 Cr
- Paid Up Capital ₹ 8.16 Cr
- Company Age 21 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.41 Cr
- Revenue Growth 44.96%
- Profit Growth 197.83%
- Ebitda 12090.12%
- Net Worth 33.47%
- Total Assets 18.14%
About Atrimed Pharmaceuticals
Atrimed Pharmaceuticals Private Limited (APPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 03 July 2003 and has a history of 21 years and seven months. Its registered office is in Bangaluru, Karnataka, India.
The Corporate was formerly known as Atrimed Herbals Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 8.50 Cr and a paid-up capital of Rs 8.16 Cr.
The company currently has active open charges totaling ₹2.41 Cr.
Hrishikesh Damle, Ganju Krishen, Latha Damle, and One other member serve as directors at the Company.
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U02423KA2003PTC032200
- Company No.
032200
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Jul 2003
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Atrimed Pharmaceuticals?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Latha Damle  | Director | 09-Sep-2021 | Current |
| Hrishikesh Damle | Director | 03-Jul-2003 | Current |
Ganju Krishen  | Director | 25-Mar-2010 | Current |
| Rishi Ganju | Director | 09-Sep-2021 | Current |
Financial Performance of Atrimed Pharmaceuticals.
Atrimed Pharmaceuticals Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 44.96% increase. The company also saw a substantial improvement in profitability, with a 197.83% increase in profit. The company's net worth Soared by an impressive increase of 33.47%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Atrimed Pharmaceuticals?
In 2021, Atrimed Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Atrimed Bio-Tech LlpHrishikesh Damle and Latha Damle are mutual person
Atrimed Health Care FoundationHrishikesh Damle is a mutual person
Damle & Ganju Health Consultants LlpHrishikesh Damle and Ganju Krishen are mutual person
- Save A Mother Foundation
Hrishikesh Damle and Latha Damle are mutual person
- Mahila Healthcare Private Limited
Hrishikesh Damle and Ganju Krishen are mutual person
- Atrimed Plant Science Private Limited
Hrishikesh Damle and Latha Damle are mutual person
Charges (Loans)
₹2.41 Cr
₹0
Charges Breakdown by Lending Institutions
- Others : 2.00 Cr
- Hdfc Bank Limited : 0.41 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Oct 2024 | Others | ₹2.00 Cr | Open |
| 31 Oct 2022 | Hdfc Bank Limited | ₹4.11 M | Open |
How Many Employees Work at Atrimed Pharmaceuticals?
Atrimed Pharmaceuticals has a workforce of 132 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Atrimed Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Atrimed Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
